BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bilim O, Takeishi Y, Kitahara T, Ishino M, Sasaki T, Suzuki S, Shishido T, Kubota I. Serum YKL-40 Predicts Adverse Clinical Outcomes in Patients With Chronic Heart Failure. Journal of Cardiac Failure 2010;16:873-9. [DOI: 10.1016/j.cardfail.2010.05.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Akboga MK, Yalcin R, Sahinarslan A, Yilmaz Demirtas C, Abaci A. Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. International Journal of Cardiology 2016;224:323-7. [DOI: 10.1016/j.ijcard.2016.09.042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
2 El-asrar MA, Elbarbary NS, Ismail EAR, Elshenity AM. Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications. Blood Cells, Molecules, and Diseases 2016;56:1-8. [DOI: 10.1016/j.bcmd.2015.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
3 Suzuki S, Shishido T, Funayama A, Netsu S, Ishino M, Kitahara T, Sasaki T, Katoh S, Otaki Y, Watanabe T, Shibata Y, Mantovani A, Takeishi Y, Kubota I. Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction. PLoS One 2013;8:e53133. [PMID: 23372656 DOI: 10.1371/journal.pone.0053133] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
4 Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 Like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5:201. [PMID: 32929074 DOI: 10.1038/s41392-020-00303-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
5 Chen G, Yang T, Gu Q, Ni X, Zhao Z, Ye J, Meng X, Liu Z, He J, Xiong C. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension: YKL-40 predicts outcomes in PAH. Respirology 2014;19:608-15. [DOI: 10.1111/resp.12283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Adrangi S, Faramarzi MA. From bacteria to human: a journey into the world of chitinases. Biotechnol Adv. 2013;31:1786-1795. [PMID: 24095741 DOI: 10.1016/j.biotechadv.2013.09.012] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 13.9] [Reference Citation Analysis]
7 Deng Y, Li G, Chang D, Su X. YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clin Chim Acta 2020;511:40-6. [PMID: 33002471 DOI: 10.1016/j.cca.2020.09.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Malyszko J, Koc-zorawska E, Malyszko J. YKL-40, a Marker of Cardiovascular Disease and Endothelial Dysfunction, in Kidney Transplant Recipients. Transplantation Proceedings 2014;46:2651-3. [DOI: 10.1016/j.transproceed.2014.09.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Bouwens E, van den Berg VJ, Akkerhuis KM, Baart SJ, Caliskan K, Brugts JJ, Mouthaan H, Ramshorst JV, Germans T, Umans VAWM, Boersma E, Kardys I. Circulating Biomarkers of Cell Adhesion Predict Clinical Outcome in Patients with Chronic Heart Failure. J Clin Med 2020;9:E195. [PMID: 31936828 DOI: 10.3390/jcm9010195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Çetin M, Kocaman S, Çanga A, Kırbaş A, Yılmaz A, Erdoğan T, Akgül Ö, Uğurlu Y, Durakoğlugil M. Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI. Herz 2013;38:202-9. [DOI: 10.1007/s00059-012-3671-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
11 Schmidt IM, Hall IE, Kale S, Lee S, He CH, Lee Y, Chupp GL, Moeckel GW, Lee CG, Elias JA, Parikh CR, Cantley LG. Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function. J Am Soc Nephrol 2013;24:309-19. [PMID: 23291472 DOI: 10.1681/ASN.2012060579] [Cited by in Crossref: 75] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
12 Kalogeropoulos AP, Georgiopoulou VV, Butler J. Clinical adoption of prognostic biomarkers: the case for heart failure. Prog Cardiovasc Dis 2012;55:3-13. [PMID: 22824105 DOI: 10.1016/j.pcad.2012.05.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
13 Zhang Y, Su X, Pan P, Hu C. The serum YKL-40 level is a potential biomarker for OSAHS: a systematic review and meta-analysis. Sleep Breath 2020;24:923-9. [PMID: 31414328 DOI: 10.1007/s11325-019-01920-5] [Reference Citation Analysis]
14 Omidian M, Mahmoudi M, Javanbakht MH, Eshraghian MR, Abshirini M, Daneshzad E, Hasani H, Alvandi E, Djalali M. Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial. Diabetes Metab Syndr 2019;13:2873-7. [PMID: 31425951 DOI: 10.1016/j.dsx.2019.07.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 de Gonzalo-calvo D, de Luxán-delgado B, Martínez-camblor P, Rodríguez-gonzález S, García-macia M, Suárez FM, Solano JJ, Rodríguez-colunga MJ, Coto-montes A. Chronic inflammation as predictor of 1-year hospitalization and mortality in elderly population: CHRONIC INFLAMMATION AS PREDICTOR OF 1-YEAR HOSPITALIZATION AND MORTALITY. European Journal of Clinical Investigation 2012;42:1037-46. [DOI: 10.1111/j.1365-2362.2012.02689.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
16 Li W, Yu Z, Jiang C. Association of Serum YKL-40 With the Presence and Severity of Obstructive Sleep Apnea Syndrome. Lab Med 2014;45:220-5. [DOI: 10.1309/lms98akcxrsl2xor] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mygind ND, Axelsson A, Ruwald MH, Dalsgaard M, Steffensen R, Iversen K, Johansen JS, Kastrup J. The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test. Cardiovasc Endocrinol 2016;5:21-7. [PMID: 28392973 DOI: 10.1097/XCE.0000000000000073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Nielsen TL, Plesner LL, Warming PE, Pallisgaard JL, Dalsgaard M, Schou M, Høst U, Rydahl C, Brandi L, Køber L, Johansen JS, Kastrup J, Iversen KK. YKL-40 in patients with end-stage renal disease receiving haemodialysis. Biomarkers 2018;23:357-63. [DOI: 10.1080/1354750x.2018.1428359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
19 Mygind ND, Iversen K, Køber L, Goetze JP, Nielsen H, Boesgaard S, Bay M, Johansen JS, Nielsen OW, Kirk V, Kastrup J. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality. J Intern Med 2013;273:205-16. [PMID: 23140269 DOI: 10.1111/joim.12006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
20 Arain F, Gullestad L, Nymo S, Kjekshus J, Cleland JG, Michelsen A, McMurray JJ, Wikstrand J, Aukrust P, Ueland T. Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA). Biomarkers 2017;22:261-7. [PMID: 27325138 DOI: 10.1080/1354750X.2016.1204003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Pala S, Sari M, Kahveci G, Alizade E, Arslantas U, Uslu A. Plasma YKL-40 Elevation on Admission and Follow-Up Is Associated with Diastolic Dysfunction and Mortality in Patients with Acute Myocardial Infarction. Cardiol Res Pract 2018;2018:8701851. [PMID: 29686891 DOI: 10.1155/2018/8701851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
22 Yang L, Dong H, Lu H, Liao Y, Zhang H, Xu L, Tan Y, Cao S, Tan J, Fu S. Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Medicine (Baltimore) 2019;98:e14920. [PMID: 30896649 DOI: 10.1097/MD.0000000000014920] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]